Wei Yang

ORCID: 0000-0003-2798-0769 · 4 papers in corpus
2023
RAS mutation nomograms to predict prognosis after radiofrequency ablation of recurrent colorectal liver metastases
·doi:10.21203/rs.3.rs-3605934/v1

Objectives: This study was conducted to develop nomograms for predicting repeat intrahepatic recurrence (rIHR) and overall survival (OS) after radiofrequency ablation (RFA) treatment in patients with recurrent colorectal liver metastases (…

article 2023
Research into the mechanism of intervention of Wenjing decoction in endometriosis based on network pharmacology and molecular docking technology
Medicine ·doi:10.1097/md.0000000000034845

BACKGROUND: Endometriosis (EMs) is a frequent disease in women and is the principal cause of infertility and dysmenorrhea. Due to its high recurrence rate and serious complications, more research on EMs is needed. We used network pharmacolo…

article 2022
NeiyiKangfu tablets control the progression of endometriosis through inhibiting RAF/MEK/ERK signal pathway by targeting RKIP
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2022.2162495

BACKGROUND: NeiyiKangfu tablets (NYKF) are widely used clinically for the treatment of endometriosis (EMS), whose mechanism of action has been extensively studied. Researchers have found that NYKF may control the development of ectopic lesi…

article 2018
Clinical Usefulness of the Microbubble Contrast Agent SonoVue in Enhancing the Effects of High‐Intensity Focused Ultrasound for the Treatment of Adenomyosis
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine ·doi:10.1002/jum.14638

OBJECTIVE: To evaluate the clinical usefulness of the microbubble contrast agent SonoVue in enhancing high-intensity focused ultrasound (HIFU) for the treatment of adenomyosis. METHODS: A total of 102 patients with adenomyosis, assessed fro…